Abbott's Galectin-3 test helps doctors for assessing prognosis of heart ... pharmabiz.com Abbott, a global healthcare company announced CE Marking (Conformite Europeenne) for the ARCHITECT Galectin-3 assay, a test to aid doctors in assessing the prognosis of patients diagnosed with chronic heart failure (HF). The ARCHITECT Galectin-3 ... |
